Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma

Clonal competition assays identify fitness signatures in cancer progression and resistance in multiple myeloma

Abstract Multiple myeloma (MM) is a genetically heterogeneous disease and the management of relapses is one of the biggest clinical challenges. TP53 alterations are established high‐risk markers and are included in the current disease staging criteria. KRAS is the most frequently mutated gene affect...

Full description

Bibliographic Details
Main Authors: Larissa Haertle, Umair Munawar, Hipólito N. C. Hernández, Andres Arroyo‐Barea, Tobias Heckel, Isabel Cuenca, Lucia Martin, Carlotta Höschle, Nicole Müller, Cornelia Vogt, Thorsten Bischler, Paula L. delCampo, Seungbin Han, Natalia Buenache, Xiang Zhou, Florian Bassermann, Johannes Waldschmidt, Torsten Steinbrunn, Leo Rasche, Thorsten Stühmer, Joaquin Martinez‐Lopez, K. Martin Kortüm, Santiago Barrio
Format: Article
Language:English
Published: Wiley 2024-07-01
Series:HemaSphere
Online Access:https://doi.org/10.1002/hem3.110

Internet

https://doi.org/10.1002/hem3.110

Similar Items